BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 19915839)

  • 1. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
    Boellaard R; O'Doherty MJ; Weber WA; Mottaghy FM; Lonsdale MN; Stroobants SG; Oyen WJ; Kotzerke J; Hoekstra OS; Pruim J; Marsden PK; Tatsch K; Hoekstra CJ; Visser EP; Arends B; Verzijlbergen FJ; Zijlstra JM; Comans EF; Lammertsma AA; Paans AM; Willemsen AT; Beyer T; Bockisch A; Schaefer-Prokop C; Delbeke D; Baum RP; Chiti A; Krause BJ
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):181-200. PubMed ID: 19915839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology.
    Stauss J; Franzius C; Pfluger T; Juergens KU; Biassoni L; Begent J; Kluge R; Amthauer H; Voelker T; Højgaard L; Barrington S; Hain S; Lynch T; Hahn K;
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1581-8. PubMed ID: 18536914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
    Rausch I; Bergmann H; Geist B; Schaffarich M; Hirtl A; Hacker M; Beyer T
    Nuklearmedizin; 2014; 53(6):242-8. PubMed ID: 25131649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: "FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0".
    Saboury B; Torigian DA; Alavi A
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1430-1; author reply 1432-3. PubMed ID: 20503048
    [No Abstract]   [Full Text] [Related]  

  • 5. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
    Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
    J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
    Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FDG-PET/CT in oncology. German Guideline].
    Krause BJ; Beyer T; Bockisch A; Delbeke D; Kotzerke J; Minkov V; Reiser M; Willich N
    Nuklearmedizin; 2007; 46(6):291-301. PubMed ID: 18084685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedure guidelines for whole-body 18F-FDG PET and PET/CT in children with malignant diseases].
    Franzius C; Stauss J; Pfluger T; Juergens KU; Kluge R; Amthauer H; Juergens H; Henze G; Stoever B; Hahn K
    Nuklearmedizin; 2010; 49(6):225-33; quiz N60-1. PubMed ID: 20617279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of quantitative imaging: the time is right, and 18F-FDG PET/CT is a good place to start.
    Buckler AJ; Boellaard R
    J Nucl Med; 2011 Feb; 52(2):171-2. PubMed ID: 21233179
    [No Abstract]   [Full Text] [Related]  

  • 10. FDG PET/CT in oncology: "raising the bar".
    Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
    Law I; Albert NL; Arbizu J; Boellaard R; Drzezga A; Galldiks N; la Fougère C; Langen KJ; Lopci E; Lowe V; McConathy J; Quick HH; Sattler B; Schuster DM; Tonn JC; Weller M
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):540-557. PubMed ID: 30519867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brief review of Japanese guidelines for the clinical use of (18)F-FDG-PET/MRI 2012 (Ver 1.0).
    Kaneta T
    Ann Nucl Med; 2013 May; 27(4):309-13. PubMed ID: 23508379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET CT for tumor imaging.
    Miller JC; Fischman AJ; Aquino SL; Blake MA; Thrall JH; Lee SI
    J Am Coll Radiol; 2007 Apr; 4(4):256-9. PubMed ID: 17412280
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma.
    Leijte JA; Graafland NM; Valdés Olmos RA; van Boven HH; Hoefnagel CA; Horenblas S
    BJU Int; 2009 Sep; 104(5):640-4. PubMed ID: 19281465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage Card.
    Tran-Gia J; Eberlein U; Lassmann M; Mauz-Körholz C; Körholz D; Zuccetta P; Bar-Sever Z; Rosner U; Georgi TW; Sabri O; Kluge R; Piccardo A; Kurch L
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):405-411. PubMed ID: 37728668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
    Boellaard R; Delgado-Bolton R; Oyen WJ; Giammarile F; Tatsch K; Eschner W; Verzijlbergen FJ; Barrington SF; Pike LC; Weber WA; Stroobants S; Delbeke D; Donohoe KJ; Holbrook S; Graham MM; Testanera G; Hoekstra OS; Zijlstra J; Visser E; Hoekstra CJ; Pruim J; Willemsen A; Arends B; Kotzerke J; Bockisch A; Beyer T; Chiti A; Krause BJ;
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):328-54. PubMed ID: 25452219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.